Medicine guide

JAKAVI

As listed in the register: JAKAVI 20 MG COMPRIMIDOS

20 mg · comprimido

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Ruxolitinib
Made by
Novartis Europharm Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01EJ01

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byNovartis Europharm Limited
Active substanceRuxolitinib
Used inCancer treatments and immune-system medicines
Strength20 mg
Formcomprimido
ClassificationL01EJ01 · Cancer treatments and immune-system medicines
Routevía oral
MarketedYes, according to the register
DrivingThe regulator flags that this medicine can affect the ability to drive.
Name in the registerJAKAVI 20 MG COMPRIMIDOS
Nº Registro112773011

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Other strengths and forms

5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.